Evidence map›Paper›PMID 39767429›Full record

ArticleInternational journal of environmental research and public health2024

Barriers and Facilitators to Vaccine Equity Amidst the COVID-19 Vaccine Rollout in the United States.

Rachael Piltch-Loeb, Josefina Nuñez Sahr, LaRon E Nelson, David Vlahov, Robyn R Gershon

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rachael Piltch-LoebInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, NY 10027, USA.
Josefina Nuñez SahrInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, NY 10027, USA.ORCID 0009-0005-1459-836X
LaRon E NelsonYale School of Nursing, New Haven, CT 06477, USA.
David VlahovYale School of Nursing, New Haven, CT 06477, USA.
Robyn R GershonDepartment of Epidemiology, New York University School of Global Public Health, New York City, NY 10003, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863Science Applications International Corporation (SAIC) NA
6 · The paper itself

Abstract

State and local health departments were responsible for ensuring equitable distribution of the COVID-19 vaccine. This qualitative study aimed to identify the challenges, strategies, disappointments, and successes in achieving equity for hard-to-reach and at-risk populations. Using a purposive sampling strategy, 16 individuals affiliated with health departments across nine states, each holding leadership roles in vaccine distribution, were interviewed between late 2021 and mid-2022. The key factors promoting vaccine equity included (1) inviting community members to serve on vaccine advisory groups to participate in decision-making; (2) utilizing pre-existing community relationships and spaces to facilitate the planning and distribution of the vaccine; and (3) establishing and building upon community outreach to support accessibility and uptake of the vaccine. The barriers included (1) a lack of clarity on vaccine prioritization criteria; (2) language/communication access; and (3) the initial focus on mass vaccination sites for vaccine delivery. The stakeholders also highlighted potential facilitators for increasing equity in future vaccine rollouts. Overall, community engagement emerged as a critical factor in ensuring equity during disaster response efforts.

Indexed as

Community ParticipationCOVID-19COVID-19 VaccinesHealthcare DisparitiesHealth EquityMass VaccinationCenters for Disease Control and Prevention, U.S.Community-Institutional RelationsDecision Making, SharedHealth PlanningHealth Services AccessibilityHumansQualitative ResearchUnited StatesCOVID-19 Vaccinescommunity engagementCOVID-19healthcare accesspublic healthqualitative studyvaccine equity

Identifiers

PMID39767429
PMCPMC11675886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.